HCID 59635808, compound → HCID 86649756, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C@:8]2([CH2:31][C:32]([O:34]C)=O)[O:13][C:12](=[O:14])[N:11]([C@H](C3C=CC(C4C=CC(=O)N(C)C=4)=CC=3)C)[CH2:10][CH2:9]2)=[CH:4][CH:3]=1.[CH2:36]([Mg]Br)[CH3:37]>C1COCC1.C(O[Ti](OC(C)C)(OC(C)C)OC(C)C)(C)C>[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2([CH2:31][C:32]3([OH:34])[CH2:37][CH2:36]3)[O:13][C:12](=[O:14])[NH:11][CH2:10][CH2:9]2)=[CH:6][CH:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of methyl 2-((S)-6-(4-fluorophenyl)-3-((S)-1-(4-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)phenyl)-ethyl)-2-oxo-1,3-oxazinan-6-yl)acetate (150 mg, 0.33 mmol), and tetraisopropoxytitanium (189 mg, 0.66 mmol) in THF (20 mL) was added 3.0 M ethylmagnesium bromide (4 mL, 12 mmol) at rt under nitrogen. Then the mixture was stirred for 2 h. The reaction was quenched with aqueous NH4Cl solution, and the mixture was filtered. The filtrate was extracted with EtOAc. The combined organic phase was washed with brine, dried over anhydrous Na2SO4, and concentrated to give the crude product, which was purified by preparative HPLC to give (S)-3-(S)-1-(4-bromophenyl)ethyl)-6-(4-fluorophenyl)-6-((1-hydroxycyclopropyl)methyl)-1,3-oxazinan-2-one (2.51 mg, 2%). 1H NMR (CDCl3): 0.03 (m, 1H), 0.18 (m, 1H), 0.49 (m, 1H), 0.60 (m, 1H), 1.43 (m, 3H), 2.08 (s, 2H), 2.26 (m, 1H), 2.37 (m, 2H), 2.88 (m, 1H), 5.53 (m, 1H), 6.66 (d, 2H), 6.97 (t, 2H), 7.16 (m, 2H), 7.26 (m, 2H).
Workup
- customThe reaction was quenched with aqueous NH4Cl solution
- filtrationthe mixture was filtered
- extractionThe filtrate was extracted with EtOAc
- washThe combined organic phase was washed with brine
- dry with materialdried over anhydrous Na2SO4
- concentrationconcentrated
- customto give the crude product, which
- customwas purified by preparative HPLC
Sources & evidence
- ORD record
- ord-252912b925b84a56b2c30b1e19c91820
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08114868B2
Reaction notes
Loading…